Literature DB >> 32495888

Sevoflurane impedes the progression of glioma through modulating the circular RNA has_circ_0012129/miR-761/TGIF2 axis.

W Xu1, R Xue, R Xia, W-W Liu, J-W Zheng, L Tang, L-Y Kang, W Wang, W-T Wei.   

Abstract

OBJECTIVE: Glioma is a highly aggressive and lethal brain tumor. Anesthetics have been shown to have important effects on the biological characteristics of cancer cells. Nevertheless, the molecular mechanism of anesthetic-mediated glioma cells progression remains unclear.
MATERIALS AND METHODS: Sevoflurane (sev) was employed to treat glioma cells. The biological characteristics (viability, colony formation, apoptosis, cell cycle, migration, and invasion) of glioma cells were determined via Cell Counting Kit-8 (CCK-8), cell colony formation, flow cytometry, PI cytometry, or transwell assays. The protein levels of Cell Cycle Dependent Kinase (CDK) 2, CDK4, E-cadherin, N-cadherin, Vimentin, and Transforming Growth Factor Beta (TGFB) induced factor homeobox 2 (TGIF2) were assessed through Western blot analysis. Glucose consumption and lactate production were measured using special commercial kits. The expression of circular RNA has_circ_0012129 (circ_0012129) and miR-761 was detected via quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). The relationship between circ_0012129 or TGIF2 and miR-761 was verified with Dual-Luciferase reporter assay. Sevoflurane-mediated molecular mechanisms have been confirmed via xenograft assay.
RESULTS: Sevoflurane suppressed viability, colony formation, cell cycle, migration, and invasion and promoted apoptosis of glioma cells in vitro, and impeded tumor growth in vivo. Circ_0012129 and TGIF2 were downregulated and miR-761 was upregulated in sevoflurane-treated glioma cells. Circ_0012129 elevation abolished sevoflurane-mediated biological characteristics of glioma cells. MiR-761 served as target for circ_0012129 and miR-761 targeted TGIF2. Moreover, both miR-761 overexpression and TGIF2 suppression restored circ_0012129 enhancement-mediated biological characteristics of sevoflurane-treated glioma cells.
CONCLUSIONS: Sevoflurane mediated the progression of glioma via regulating the circ_0012129/miR-761/TGIF2 axis.

Entities:  

Year:  2020        PMID: 32495888     DOI: 10.26355/eurrev_202005_21339

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  8 in total

1.  Sevoflurane represses the progression of glioma by the regulation of circ_0037655/miR-130a-5p/RPN2 axis.

Authors:  Jinyou Zhu; Bin Xie; Guiming Huang; Yiping Li; Zhenhua Liu
Journal:  Metab Brain Dis       Date:  2022-01-15       Impact factor: 3.584

2.  Sevoflurane Suppresses the Proliferation, Migration and Invasion of Colorectal Cancer Through Regulating Circ_0000423/miR-525-5p/SGPP1 Network.

Authors:  Xiaofang Kang; Xiaocong Li; Yanli Li
Journal:  Cell Mol Bioeng       Date:  2022-01-22       Impact factor: 2.321

3.  Sevoflurane impedes glioma progression via regulating circ_0000215/miR-1200/NCR3LG1 axis.

Authors:  Zhitao Zhao; Baofeng Gao; Xiaoling Zong; Ruiming Gao
Journal:  Metab Brain Dis       Date:  2021-08-30       Impact factor: 3.584

4.  Lidocaine has antitumor effect on hepatocellular carcinoma via the circ_DYNC1H1/miR-520a-3p/USP14 axis.

Authors:  Hua Liu; Jing Cheng; Heng Xu; Zhenzhen Wan
Journal:  Open Life Sci       Date:  2021-08-09       Impact factor: 0.938

5.  Sevoflurane inhibits progression of glioma via regulating the HMMR antisense RNA 1/microRNA-7/cyclin dependent kinase 4 axis.

Authors:  Xi'an Bao; Yibo Peng; Jun Shen; Longqiu Yang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 6.  Effect of Inhalation Anesthetics on Tumor Metastasis.

Authors:  Yixin Jing; Yiguo Zhang; Rui Pan; Ke Ding; Rong Chen; Qingtao Meng
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

7.  Sevoflurane blocks glioma malignant development by upregulating circRELN through circRELN-mediated miR-1290/RORA axis.

Authors:  Xiaofang Kang; Hongxia Li; Zaiwang Zhang
Journal:  BMC Anesthesiol       Date:  2021-09-03       Impact factor: 2.217

8.  Sevoflurane Suppresses Colon Cancer Cell Malignancy by Regulating circ-PI4KA.

Authors:  Suqing Sun; Peng Wang; Lijie Ren; Hongli Wang; Yanli Zhan; Shimin Shan
Journal:  Onco Targets Ther       Date:  2021-05-20       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.